177
Participants
Start Date
March 31, 2022
Primary Completion Date
April 15, 2023
Study Completion Date
July 12, 2023
RMC-035
Concentrate for Solution for Infusion
Placebo
Concentrate for Solution for Infusion
Rochester Regional Health - Rochester General Hospital, Rochester
University of Virginia (UVA) Health - University Hospital, Charlottesville
Duke University Hospital, Durham
Indiana Ohio Heart, Fort Wayne
Aurora Health Care - Aurora St. Luke's Medical Center, Milwaukee
University of Wisconsin, Madison
Bryan Heart, Lincoln
Baylor Scott and White Research Institute - Dallas, Dallas
Hamilton Health Sciences, Hamilton
CHUM, Montreal
MUHC - Royal Victoria Hospital, Montreal
Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec
St. John Regional Hospital, Saint John
Saint Michael's Hospital, Toronto
University Hospital Hradec Kralove, Hradec Králové
University Hospital Motol - Charles University Prague, Prague
Herz- und Diabeteszentrum Nordrhein-Westfalen (NRW), Bad Oeynhausen
Universitätsklinikum Köln, Cologne
Herzzentrum Dresden GmbH, Dresden
Westdeutsches Herzzentrum Essen, Essen
Universitätsklinikum Giessen und Marburg - Standort Giessen, Giessen
Universitätsklinikum Halle (Saale), Halle
Deutsches Herzzentrum München, München
Hospital Sant Pau, Barcelona
Reina Sofia University Hospital, Córdoba
Hospital de La Princesa, Madrid
Hospital Universitario Central de Asturias, Oviedo
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela
Münster University Hospital, Münster
Lead Sponsor
Guard Therapeutics AB
INDUSTRY